| 
		Britons can be confident in vaccine monitoring, health secretary says
		 Send a link to a friend 
		
		 [April 08, 2021] 
		LONDON (Reuters) -Britons should be 
		confident that the system to monitor COVID-19 vaccines is working 
		following the change in advice on giving young people the 
		Oxford-AstraZeneca jab, Health Secretary Matt Hancock said on Thursday. 
 "People can be reassured that we have the high class safety system run 
		by our world class regulator (...) and then we're totally transparent 
		with all of the side effects, no matter how extremely rare they are like 
		these ones," he told Sky News.
 
 Britain's vaccine advisory committee said on Wednesday that an 
		alternative to Oxford-AstraZeneca's vaccine should be given to under 30s 
		where possible due to a "vanishingly" rare side effect of blood clots in 
		the brain.
 
		
		 
		Hancock said new guidance would not delay Britain's vaccination 
		programme because alternatives from Pfizer and Moderna would be 
		available for the affected group.
 Britain is aiming to give a first dose of COVID-19 vaccine all over-50s 
		by mid-April and all adults by the end of July.
 
 [to top of second column]
 | 
            
			 
            
			Britain's Health Secretary Matt Hancock holds a news conference at 
			10 Downing Street, amid the coronavirus disease (COVID-19) outbreak, 
			in London, Britain March 17, 2021. REUTERS/Hannah McKay/Pool 
            
			 
            Hancock said there were 10.16 million people aged between 18 to 29, 
			of whom 1.6 million had already had a first dose of vaccine.
 "We have more than enough Pfizer and Moderna vaccines to cover all 
			of the remaining eight and a half million people," he said.
 
 "We are on track to hit the target that we've set that we will 
			ensure every adult in the UK is offered the jab by the end of July."
 
 (Reporting by Paul Sandle and Sarah Young; editing by Costas Pitas 
			and Alistair Smout)
 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |